The veterinary medicinal product, which is the subject of the application, shall be identified by its name and by the name of the active substance(s), together with the strength, the pharmaceutical form, the route and method of administration (see Article 12(3)(f) of Directive) and a description of the final presentation of the product, including packaging, labelling and package leaflet (see Article 12(3)–(l) of Directive).
Déanfar an táirge íocshláinte tréidliachta is ábhar don iarratas a shainaithint trí úsáid a bhaint as a ainm agus as ainm na substainte gníomhaí/substaintí gníomhacha, maille leis an neart, leis an bhfoirm chógaisíochta, leis an mbealach agus an modh ina dtugtar é (féach pointe (f) d’Airteagal 12(3) den Treoir) agus le tuairisc ar chur i láthair deiridh an táirge, lena n-áirítear an pacáistiú, an lipéadú agus bileog phacáiste (féach Airteagal 12(3) –(l) den Treoir).